-
1.
公开(公告)号:US20050085411A1
公开(公告)日:2005-04-21
申请号:US10744964
申请日:2003-12-23
申请人: Peter Howley , John Benson , Hiroaki Kasukawa
发明人: Peter Howley , John Benson , Hiroaki Kasukawa
IPC分类号: A61K38/00 , A61K48/00 , C07K14/025 , G01N33/50 , G01N33/68 , A61K38/16 , A61K38/06 , A61K38/08 , A61K38/10
CPC分类号: G01N33/5011 , A61K38/00 , A61K48/00 , C07K14/005 , C07K2319/00 , C12N2710/20022 , G01N33/5008 , G01N33/502 , G01N33/5044 , G01N33/68
摘要: By virtue of the present invention, there is provided methods and compositions for interfering with the proliferation of cells infected and/or transformed by papillomaviruses. The processes and compositions of this invention may be used to treat any mammal, including humans. According to this invention, mammals are treated by the pharmaceutically acceptable administration of an E2 peptidomimetic to reduce the symptoms of the specific papillomavirus-associated disease, or to prevent their recurrence.
摘要翻译: 根据本发明,提供了用于干扰由乳头瘤病毒感染和/或转化的细胞的增殖的方法和组合物。 本发明的方法和组合物可用于治疗包括人在内的任何哺乳动物。 根据本发明,通过药学上可接受的施用E2肽模拟物治疗哺乳动物以减少特异性乳头瘤病毒相关疾病的症状,或防止其复发。
-
公开(公告)号:US20060223055A1
公开(公告)日:2006-10-05
申请号:US11322164
申请日:2005-12-29
申请人: Peter Howley , Jianxin You
发明人: Peter Howley , Jianxin You
CPC分类号: C07K14/47 , A61K38/00 , A61K2039/505 , C07K14/005 , C07K16/084 , C07K2319/00 , C07K2319/42 , C07K2319/43 , C12N2710/20022
摘要: The present invention relates to methods and compositions for the treatment and/or prevention of diseases or disorders associated with viral infection. Accordingly, the nucleotide and amino acid sequences for a human Brd4 protein are provided. Also provided are complexes comprising Brd4 and an E2 protein or a functional equivalent of an E2 protein.
摘要翻译: 本发明涉及用于治疗和/或预防与病毒感染相关的疾病或病症的方法和组合物。 因此,提供了人Brd4蛋白的核苷酸和氨基酸序列。 还提供了包含Brd4和E2蛋白或E2蛋白的功能等同物的复合物。
-
公开(公告)号:US20050123902A1
公开(公告)日:2005-06-09
申请号:US10851407
申请日:2004-05-21
申请人: Patricio Meneses , Angela Koehler , Jason Wong , Peter Howley , Stuart Schreiber
发明人: Patricio Meneses , Angela Koehler , Jason Wong , Peter Howley , Stuart Schreiber
IPC分类号: A61K31/41 , A61K38/00 , C07K14/025 , G01N33/569 , C12Q1/70 , C07K7/08
CPC分类号: C07K14/005 , A61K31/41 , A61K38/00 , C12N2710/20022 , G01N33/56983 , G01N2333/025 , G01N2500/02
摘要: The present invention provides systems for identifying anti-viral agents. In particular, the invention encompasses reagents and strategies for identifying agents that inhibit or disrupt key protein-protein interactions that are important in the life cycle of papillomaviruses. The invention allows identification, production, and/or use of agents that reduce or inhibit the replication of HPV by inhibiting (e.g., precluding, reversing, or disrupting) the formation of the E1-E2 protein-protein complex. The invention also provides specific inhibitory agents, pharmaceutical compositions, and methods of using these inhibitors and pharmaceutical compositions for inhibiting viral replication in vitro. Methods are also described for the treatment and prevention of HPV infections and HPV-related diseases in patients.
摘要翻译: 本发明提供用于鉴定抗病毒剂的系统。 特别地,本发明包括用于鉴定抑制或破坏在乳头状瘤病毒生命周期中重要的关键蛋白质 - 蛋白质相互作用的试剂的策略。 本发明允许通过抑制(例如排除,逆转或破坏)E1-E2蛋白 - 蛋白复合物的形成来鉴定,产生和/或使用降低或抑制HPV复制的药剂。 本发明还提供特异性抑制剂,药物组合物和使用这些抑制剂和药物组合物用于体外抑制病毒复制的方法。 还描述了用于治疗和预防患者的HPV感染和HPV相关疾病的方法。
-
-